(Q48475883)

11 February 2018

title

How effective is citicoline for acute ischaemic stroke? (English)

1 reference

11 February 2018

author

Graeme J. Hankey

series ordinal

1

1 reference

11 February 2018

language of work or name

English

0 references

publication date

11 June 2012

1 reference

11 February 2018

published in

The Lancet

1 reference

11 February 2018

volume

380

1 reference

11 February 2018

issue

9839

1 reference

11 February 2018

page(s)

318-320

1 reference

11 February 2018

Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Stroke and neurovascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Citicoline preclinical and clinical update 2009-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Citicoline enhances neuroregenerative processes after experimental stroke in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

A randomized efficacy trial of citicoline in patients with acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

What is heterogeneity and is it important?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

Large trials vs meta-analysis of smaller trials: how do their results compare?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960912-X

7 January 2021

10.1016/S0140-6736(12)60912-X

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018